CANADA LIFE ASSURANCE Co - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$81
+107.7%
3,547
+50.1%
0.00%
Q2 2023$39
-7.1%
2,3630.0%0.00%
Q1 2023$42
-39.1%
2,3630.0%0.00%
Q4 2022$69
-99.9%
2,3630.0%0.00%
Q3 2022$58,000
+480.0%
2,3630.0%0.00%
Q2 2022$10,000
-65.5%
2,3630.0%0.00%
Q1 2022$29,000
+26.1%
2,3630.0%0.00%
Q4 2021$23,000
-25.8%
2,3630.0%0.00%
Q3 2021$31,000
-32.6%
2,3630.0%0.00%
Q2 2021$46,000
-8.0%
2,3630.0%0.00%
Q1 2021$50,000
-28.6%
2,3630.0%0.00%
Q4 2020$70,000
+37.3%
2,3630.0%0.00%
Q3 2020$51,000
-1.9%
2,3630.0%0.00%
Q2 2020$52,000
+44.4%
2,3630.0%0.00%
Q1 2020$36,000
-33.3%
2,3630.0%0.00%
Q4 2019$54,000
-5.3%
2,363
-9.5%
0.00%
Q2 2019$57,000
-19.7%
2,6100.0%0.00%
Q1 2019$71,000
+4.4%
2,6100.0%0.00%
Q4 2018$68,0002,6100.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 4,909,956$142,977,9198.04%
Opaleye Management Inc. 735,000$21,403,2007.44%
Frazier Life Sciences Management, L.P. 1,894,000$55,153,2803.43%
RA Capital Management 5,516,067$160,627,8713.26%
Altium Capital Management LP 170,000$4,950,4002.52%
Samsara BioCapital, LLC 345,293$10,054,9322.16%
Rock Springs Capital Management LP 1,760,865$51,276,3891.23%
Parkman Healthcare Partners LLC 157,862$4,596,9411.22%
Baker Brothers Advisors 6,354,608$185,046,1851.11%
EAM Investors, LLC 164,695$4,795,9180.99%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders